Schedule 13D ownership disclosure
Mirna Therapeutics, Inc.
Security class unavailable · CUSIP: 60470J103
Event date: 2015-10-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,974,811
- Percent of class
- 14.1700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-058615
- Form type
- SC 13D
- Filer
- SYNLOGIC, INC.
- CIK
- CIK 1527599
- Filed
- Oct 08, 2015
- Reporting period
- Oct 05, 2015
- Description
- Schedule 13D beneficial ownership